Simulated Treatment Comparison (STC) of Human Mesenchymal Stromal Cells (Remestemcel-L, REM) and Ruxolitinib (RUX) for Steroid-Refractory Acute Graft-Versus-Host Disease (SR aGVHD) Pediatric Patients
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-131098
Abstract: Introduction: Allo-HSCT was performed on 1771 US children in 2016. SR aGVHD is a life-threatening complication of allo-HSCT associated with substantial healthcare costs and significant reductions in pediatric QOL. Grade II-IV aGVHD occurs in 39-59%… read more here.
Keywords: trial; rux; age; rem ... See more keywords